Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.

ARB Trialists Collaboration
J Hypertens. 2011 29 (4): 623-35

PMID: 21358417 · DOI:10.1097/HJH.0b013e328344a7de

MeSH Terms (14)

Angiotensin-Converting Enzyme Inhibitors Benzimidazoles Benzoates Biphenyl Compounds Case-Control Studies Double-Blind Method Humans Hypertension Irbesartan Losartan Neoplasms Randomized Controlled Trials as Topic Telmisartan Tetrazoles

Connections (1)

This publication is referenced by other Labnodes entities: